OpenAI CEO Sam Altman recently expressed his concerns about AI regulation in a discussion with the US Senate. Altman described the potential “significant harm”that AI technology and industry may be responsible for, while also emphasizing the potential benefits AI can bring in terms of fighting disease, curing cancer and dealing with climate change.
The CEO identified the dangers posed by AI, such as the influence on elections, financial markets, the job market, and the risk of malicious actors creating counterfeit people. He suggested a licensing scheme for AI models with strong capacity in the future as artificial general intelligence, as well as safety standards and independent audits.
Altman also pointed out the necessity of distinguishing human users from AI users to provide trust of AI for the consumers, similarly how consumers are aware of how images can be photoshopped. IBM’s chief of trust Christina Montgomery agreed that transparency and disclosure of AI training, along with governance of the technology, are key to mitigating AI-related harms. Cognitive scientist Gary Marcus, meanwhile, proposed measures like those enforced by the FDA, as well as safety research investment.
OpenAI is a research laboratory based in San Francisco, California. Founded in 2015, the company focuses on the development of artificial intelligence technologies and products. With over 200 team members, OpenAI works to create advanced technologies that are beneficial for the society.
Sam Altman is one of the most important tech influencers of Silicon Valley. After graduating from Stanford University, he became the president of Y Combinator in 2014. Three years later he helped to form OpenAI and currently worked as the CEO of the company. He is also an entrepreneur, executive and investor, as well as a board member of Tech:NYC and a partner at Y Combinator.
